231 related articles for article (PubMed ID: 36172362)
21. Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
Zhang W; Chen X; Gao G; Xing S; Zhou L; Tang X; Zhao X; An Y
Front Immunol; 2021; 12():654406. PubMed ID: 33777053
[No Abstract] [Full Text] [Related]
22. Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation.
Kayaoglu B; Kasap N; Yilmaz NS; Charbonnier LM; Geckin B; Akcay A; Eltan SB; Ozturk G; Ozen A; Karakoc-Aydiner E; Chatila TA; Gursel M; Baris S
J Clin Immunol; 2021 May; 41(4):769-779. PubMed ID: 33475942
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional Profiling of STAT1 Gain-of-Function Reveals Common and Mutation-Specific Fingerprints.
Giovannozzi S; Demeulemeester J; Schrijvers R; Gijsbers R
Front Immunol; 2021; 12():632997. PubMed ID: 33679782
[TBL] [Abstract][Full Text] [Related]
24. Severe Early-Onset Combined Immunodeficiency due to Heterozygous Gain-of-Function Mutations in STAT1.
Baris S; Alroqi F; Kiykim A; Karakoc-Aydiner E; Ogulur I; Ozen A; Charbonnier LM; Bakır M; Boztug K; Chatila TA; Barlan IB
J Clin Immunol; 2016 Oct; 36(7):641-8. PubMed ID: 27379765
[TBL] [Abstract][Full Text] [Related]
25. A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis.
Eslami N; Tavakol M; Mesdaghi M; Gharegozlou M; Casanova JL; Puel A; Okada S; Arshi S; Bemanian MH; Fallahpour M; Molatefi R; Seif F; Zoghi S; Rezaei N; Nabavi M
Acta Microbiol Immunol Hung; 2017 Jun; 64(2):191-201. PubMed ID: 28597685
[TBL] [Abstract][Full Text] [Related]
26. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
[TBL] [Abstract][Full Text] [Related]
27. STAT1 gain-of-function and chronic demodicosis.
Molho-Pessach V; Meltser A; Kamshov A; Ramot Y; Zlotogorski A
Pediatr Dermatol; 2020 Jan; 37(1):153-155. PubMed ID: 31637766
[TBL] [Abstract][Full Text] [Related]
28. Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors.
Borgström EW; Edvinsson M; Pérez LP; Norlin AC; Enoksson SL; Hansen S; Fasth A; Friman V; Kämpe O; Månsson R; Estupiñán HY; Wang Q; Ziyang T; Lakshmikanth T; Smith CIE; Brodin P; Bergman P
J Clin Immunol; 2023 Jan; 43(1):136-150. PubMed ID: 36050429
[TBL] [Abstract][Full Text] [Related]
29. Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel
Erdős M; Jakobicz E; Soltész B; Tóth B; Bata-Csörgő Z; Maródi L
Front Immunol; 2020; 11():967. PubMed ID: 32547544
[TBL] [Abstract][Full Text] [Related]
30. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
Egri N; Esteve-Solé A; Deyà-Martínez À; Ortiz de Landazuri I; Vlagea A; García AP; Cardozo C; Garcia-Vidal C; Bartolomé CS; Español-Rego M; Yiyi L; Bosch-Amate X; Ferrando J; Yagüe J; Juan M; Alsina L
Allergol Immunopathol (Madr); 2021; 49(1):118-127. PubMed ID: 33528939
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations.
Lobo PB; Guisado-Hernández P; Villaoslada I; de Felipe B; Carreras C; Rodriguez H; Carazo-Gallego B; Méndez-Echevarria A; Lucena JM; Aljaro PO; Castro MJ; Noguera-Uclés JF; Milner JD; McCann K; Zimmerman O; Freeman AF; Lionakis MS; Holland SM; Neth O; Olbrich P
J Clin Immunol; 2022 Aug; 42(6):1193-1204. PubMed ID: 35507130
[TBL] [Abstract][Full Text] [Related]
32. Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice.
Tamaura M; Satoh-Takayama N; Tsumura M; Sasaki T; Goda S; Kageyama T; Hayakawa S; Kimura S; Asano T; Nakayama M; Koseki H; Ohara O; Okada S; Ohno H; Kobayashi M
Int Immunol; 2020 Apr; 32(4):259-272. PubMed ID: 31867619
[TBL] [Abstract][Full Text] [Related]
33. New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.
Soltész B; Tóth B; Shabashova N; Bondarenko A; Okada S; Cypowyj S; Abhyankar A; Csorba G; Taskó S; Sarkadi AK; Méhes L; Rozsíval P; Neumann D; Chernyshova L; Tulassay Z; Puel A; Casanova JL; Sediva A; Litzman J; Maródi L
J Med Genet; 2013 Sep; 50(9):567-78. PubMed ID: 23709754
[TBL] [Abstract][Full Text] [Related]
34. Systems Immunology Analyses of
Kaviany S; Bartkowiak T; Dulek DE; Khan YW; Hayes MJ; Schaefer SG; Ye X; Dahunsi DO; Connelly JA; Irish JM; Rathmell JC
Immunohorizons; 2022 Jul; 6(7):447-464. PubMed ID: 35840326
[TBL] [Abstract][Full Text] [Related]
35. The pathogenic T387A missense mutation in the gene encoding signal transducer and activator of transcription 1 exhibits a differential gene expression profile.
Staab J; Schwämmle T; Meyer T
Mol Immunol; 2020 Dec; 128():79-88. PubMed ID: 33096415
[TBL] [Abstract][Full Text] [Related]
36. Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants.
Petersen J; Staab J; Bader O; Buhl T; Ivetic A; Meyer T
Mol Immunol; 2019 Oct; 114():30-40. PubMed ID: 31336247
[TBL] [Abstract][Full Text] [Related]
37. Bronchiectasis and Recurrent Respiratory Infections with a
Huh HJ; Jhun BW; Choi SR; Kim YJ; Yun SA; Nham E; Kong T; Ki CS; Koh WJ
Yonsei Med J; 2018 Oct; 59(8):1004-1007. PubMed ID: 30187709
[TBL] [Abstract][Full Text] [Related]
38. Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant.
Blanco Lobo P; Lei WT; Pelham SJ; Guisado Hernández P; Villaoslada I; de Felipe B; Lucena JM; Casanova JL; Olbrich P; Puel A; Neth O
Pediatr Allergy Immunol; 2021 Nov; 32(8):1804-1812. PubMed ID: 34289170
[TBL] [Abstract][Full Text] [Related]
39. HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis.
Rösler B; Wang X; Keating ST; Joosten LAB; Netea MG; van de Veerdonk FL
Clin Exp Immunol; 2018 Nov; 194(2):205-219. PubMed ID: 30069986
[TBL] [Abstract][Full Text] [Related]
40. Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis.
Mizoguchi Y; Tsumura M; Okada S; Hirata O; Minegishi S; Imai K; Hyakuna N; Muramatsu H; Kojima S; Ozaki Y; Imai T; Takeda S; Okazaki T; Ito T; Yasunaga S; Takihara Y; Bryant VL; Kong XF; Cypowyj S; Boisson-Dupuis S; Puel A; Casanova JL; Morio T; Kobayashi M
J Leukoc Biol; 2014 Apr; 95(4):667-76. PubMed ID: 24343863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
